Details for New Drug Application (NDA): 012223
✉ Email this page to a colleague
NDA 012223 describes AQUAMEPHYTON, which is a drug marketed by Pai Holdings Pharm and is included in one NDA. Additional details are available on the AQUAMEPHYTON profile page.
The generic ingredient in AQUAMEPHYTON is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
The generic ingredient in AQUAMEPHYTON is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 012223
| Tradename: | AQUAMEPHYTON |
| Applicant: | Pai Holdings Pharm |
| Ingredient: | phytonadione |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
